Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

With the success of chimeric antigen receptor-modified (CAR) T-cell therapy for relapsed/refractory (r/r) B-cell malignancies, severe complications after CAR T-cell infusion have emerged as nonnegligible prognosis-related factors. However, the prognosis of patients with CAR T-cell-related hyperferri...

Full description

Bibliographic Details
Main Authors: Lanlan Zhou, Nanzhou Yu, Tongjuan Li, Hongyan Ji, Lijun Jiang, Di Wang, Bin Xu, Xiaoxi Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
B-cell malignancies
CAR T-cell therapy
hyperferritinaemia
prognosis
clinical characteristics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.912689/full

Similar Items

Similar Items